Related Experiment Video
Updated: May 24, 2026

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney
Published on: November 1, 2018
MicroRNAs and the glomerulus
Mitsuo Kato1, Jung Tak Park, Rama Natarajan
1Department of Diabetes, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA. RNatarajan@coh.org
Abstract:
MicroRNAs (miRNAs) are short non-coding RNAs regulating gene expression at the post-transcriptional level by blocking translation or promoting cleavage of their target mRNAs. Increasing evidence shows that miRNAs play central roles in gene transcription, signal transduction and pathogenesis of human diseases. Diabetic nephropathy (DN) is a severe microvascular complication that can lead to end-stage renal disease. Increased expansion (hypertrophy) and accumulation of extracellular matrix (ECM) proteins such as collagen (fibrosis) in the glomerular mesangium along with glomerular podocyte dysfunction are major features of DN. Profiling of miRNAs and study\ of their functions in renal glomeruli can provide critical new information to advance our knowledge of DN as well as other kidney diseases and thereby uncover much needed new therapeutic targets. In this review, we summarize the biogenesis of miRNAs and their functions in the glomerulus, with particular emphasis on glomerular mesangial cells and podocytes related to the pathogenesis of DN.
Insights
MicroRNAs (miRNAs) regulate gene expression and are implicated in human diseases like diabetic nephropathy (DN). This review focuses on miRNA roles in the glomerulus, particularly in mesangial cells and podocytes, for potential therapeutic targets in DN.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
- Dysregulation of miRNAs is linked to the pathogenesis of various human diseases.
- Diabetic nephropathy (DN) is a major cause of end-stage renal disease, characterized by glomerular hypertrophy, fibrosis, and podocyte dysfunction.
Purpose of the Study:
- To review the biogenesis and function of miRNAs in the renal glomerulus.
- To highlight the specific roles of miRNAs in glomerular mesangial cells and podocytes in DN pathogenesis.
- To identify potential miRNA-based therapeutic targets for DN.
Main Methods:
- Literature review of miRNA biogenesis and function.
- Analysis of studies investigating miRNA expression and roles in DN.
- Focus on glomerular cell types (mesangial cells, podocytes) in DN.
Main Results:
- miRNAs are crucial regulators of cellular processes within the glomerulus.
- Altered miRNA profiles are associated with DN development and progression.
- Specific miRNAs impact mesangial cell proliferation, ECM production, and podocyte function in DN.
Conclusions:
- Understanding miRNA mechanisms in the glomerulus is vital for advancing DN research.
- miRNAs represent promising therapeutic targets for preventing or treating diabetic nephropathy.
- Further investigation into glomerular miRNA functions can uncover novel strategies for kidney disease management.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerular Filtration
Components of the Filtration Membrane
The filtration process involves three key layers: the glomerular endothelial cells, the basement membrane, and the podocyte-formed filtration slits.
Nephrons
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Drug Elimination by Renal Route: Glomerular Filtration

